Rank 78 • MedTech & Devices
Theranica
Creates Nerivio, a wearable bioelectronic neuromodulation device for acute and preventive migraine treatment.
Visit website- Signal Score
- 83.7
- Total raised
- $85M
- Stage
- Series C
- Founded
- 2015
- Headquarters
- Netanya, Israel
- Region
- Middle East & Africa
Their signal
The company is successfully commercializing drug-free neuromodulation, proving that digital therapeutics can capture significant consumer and clinical market share within highly competitive chronic pain spaces.
Signal Score 83.7editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.